Identification and guided treatment of ventricular dysfunction in general practice using B-type natriuretic peptide

D Mant; Frederick Hobbs; P Glasziou; L Wright; R Hare; R Perera; M Cowie

doi:10.3399/bjgp08X299209

Identification and guided treatment of ventricular dysfunction in general practice using B-type natriuretic peptide

D Mant, Frederick Hobbs, P Glasziou, L Wright, R Hare, R Perera, M Cowie

Research output: Contribution to journal › Article

7 Citations (Scopus)

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) is a blood test which detects ventricular wall stretch and is being increasingly used in primary care on limited evidence. AIM: To assess the practical implications and potential clinical benefit of measuring BNP to identify and guide the treatment of undiagnosed or under-treated ventricular dysfunction in at-risk patients. DESIGN OF STUDY: Screening study with single-arm intervention. SETTING: A total of 1918 patients with diabetes mellitus or ischaemic heart disease aged > or =65 years registered with 12 general practices were invited; 76 patients with elevated BNP underwent BNP-guided treatment titration. METHOD: Eligible patients were invited to attend for a blood test at their own practice; those with a persistently elevated plasma BNP concentration (>43.3 pmol/l) after repeat measurement were offered initiation or up-titration of treatment guided by remeasurement of BNP with a target concentration of

Original language	English
Pages (from-to)	393-9
Number of pages	7
Journal	British Journal of General Practice
Volume	58
Issue number	551
DOIs	https://doi.org/10.3399/bjgp08X299209
Publication status	Published - 1 Jan 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3399/bjgp08X299209

Cite this

@article{58418de1f5854c7783717c186ba7a31d,

title = "Identification and guided treatment of ventricular dysfunction in general practice using B-type natriuretic peptide",

abstract = "BACKGROUND: B-type natriuretic peptide (BNP) is a blood test which detects ventricular wall stretch and is being increasingly used in primary care on limited evidence. AIM: To assess the practical implications and potential clinical benefit of measuring BNP to identify and guide the treatment of undiagnosed or under-treated ventricular dysfunction in at-risk patients. DESIGN OF STUDY: Screening study with single-arm intervention. SETTING: A total of 1918 patients with diabetes mellitus or ischaemic heart disease aged > or =65 years registered with 12 general practices were invited; 76 patients with elevated BNP underwent BNP-guided treatment titration. METHOD: Eligible patients were invited to attend for a blood test at their own practice; those with a persistently elevated plasma BNP concentration (>43.3 pmol/l) after repeat measurement were offered initiation or up-titration of treatment guided by remeasurement of BNP with a target concentration of ",

author = "D Mant and Frederick Hobbs and P Glasziou and L Wright and R Hare and R Perera and M Cowie",

year = "2008",

month = jan,

day = "1",

doi = "10.3399/bjgp08X299209",

language = "English",

volume = "58",

pages = "393--9",

journal = "British Journal of General Practice",

issn = "1478-5242",

publisher = "Royal College of General Practitioners",

number = "551",

}

TY - JOUR

T1 - Identification and guided treatment of ventricular dysfunction in general practice using B-type natriuretic peptide

AU - Mant, D

AU - Hobbs, Frederick

AU - Glasziou, P

AU - Wright, L

AU - Hare, R

AU - Perera, R

AU - Cowie, M

PY - 2008/1/1

Y1 - 2008/1/1

N2 - BACKGROUND: B-type natriuretic peptide (BNP) is a blood test which detects ventricular wall stretch and is being increasingly used in primary care on limited evidence. AIM: To assess the practical implications and potential clinical benefit of measuring BNP to identify and guide the treatment of undiagnosed or under-treated ventricular dysfunction in at-risk patients. DESIGN OF STUDY: Screening study with single-arm intervention. SETTING: A total of 1918 patients with diabetes mellitus or ischaemic heart disease aged > or =65 years registered with 12 general practices were invited; 76 patients with elevated BNP underwent BNP-guided treatment titration. METHOD: Eligible patients were invited to attend for a blood test at their own practice; those with a persistently elevated plasma BNP concentration (>43.3 pmol/l) after repeat measurement were offered initiation or up-titration of treatment guided by remeasurement of BNP with a target concentration of

AB - BACKGROUND: B-type natriuretic peptide (BNP) is a blood test which detects ventricular wall stretch and is being increasingly used in primary care on limited evidence. AIM: To assess the practical implications and potential clinical benefit of measuring BNP to identify and guide the treatment of undiagnosed or under-treated ventricular dysfunction in at-risk patients. DESIGN OF STUDY: Screening study with single-arm intervention. SETTING: A total of 1918 patients with diabetes mellitus or ischaemic heart disease aged > or =65 years registered with 12 general practices were invited; 76 patients with elevated BNP underwent BNP-guided treatment titration. METHOD: Eligible patients were invited to attend for a blood test at their own practice; those with a persistently elevated plasma BNP concentration (>43.3 pmol/l) after repeat measurement were offered initiation or up-titration of treatment guided by remeasurement of BNP with a target concentration of

U2 - 10.3399/bjgp08X299209

DO - 10.3399/bjgp08X299209

M3 - Article

C2 - 18505615

SN - 1478-5242

VL - 58

SP - 393

EP - 399

JO - British Journal of General Practice

JF - British Journal of General Practice

IS - 551

ER -

Identification and guided treatment of ventricular dysfunction in general practice using B-type natriuretic peptide

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this